MKNK2

MKNK2

MKNK2

Protein-coding gene in the species Homo sapiens


MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme that in humans is encoded by the MKNK2 gene.[5][6]

Quick Facts Available structures, PDB ...

Interactions

MNK2 has been shown to interact with MAPK1[7][8] and Eukaryotic translation initiation factor 4 gamma.[7]

MNK2 has been identified as a therapeutic target for diabetes. Specifically, blocking MNK2 interaction with eIF4G has been shown to boost protein synthesis and promote beta cell regeneration.[9]


References

  1. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  2. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. Slentz-Kesler K, Moore JT, Lombard M, Zhang J, Hollingsworth R, Weiner MP (October 2000). "Identification of the human Mnk2 gene (MKNK2) through protein interaction with estrogen receptor beta". Genomics. 69 (1): 63–71. doi:10.1006/geno.2000.6299. PMID 11013076.
  4. Scheper GC, Parra JL, Wilson M, Van Kollenburg B, Vertegaal AC, Han ZG, Proud CG (August 2003). "The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization". Molecular and Cellular Biology. 23 (16): 5692–5705. doi:10.1128/MCB.23.16.5692-5705.2003. PMC 166352. PMID 12897141.
  5. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA (April 1997). "Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2". The EMBO Journal. 16 (8): 1909–1920. doi:10.1093/emboj/16.8.1909. PMC 1169794. PMID 9155017.
  6. Karampelias C, Watt K, Mattsson CL, Ruiz ÁF, Rezanejad H, Mi J, et al. (September 2022). "MNK2 deficiency potentiates β-cell regeneration via translational regulation". Nature Chemical Biology. 18 (9): 942–953. doi:10.1038/s41589-022-01047-x. PMC 7613404. PMID 35697798.

Further reading


Share this article:

This article uses material from the Wikipedia article MKNK2, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.